DRD3

DRD3 is a G protein-coupled dopamine receptor that shapes reward, social behavior, and dopaminergic circuit plasticity while also coupling receptor signaling to autophagy and inflammasome control (PMID:29276054, PMID:31538542). In the brain, Drd3 in lateral septum neurons is necessary and sufficient for normal social behavior, and its early-life-stress-induced downregulation blunts social-stimulus-evoked neuronal activity that optogenetic or pharmacological reactivation rescues (PMID:29276054). Within reward circuitry, DRD3-dependent plasticity in the ventral pallidum drives a pallido-habenular projection that potentiates accumbal dopamine release during cocaine relapse (PMID:34048697), and Drd3 reward function is gated transcriptionally and temporally by the circadian factor NPAS2, which binds the Drd3 promoter to impose diurnal expression in nucleus accumbens D1 neurons (PMID:25444159). At the signaling level, DRD3 — but not DRD2 — activates autophagy through an AMPK→RPTOR→MTORC1 inhibition→ULK1 cascade while preserving protein synthesis via the MAPK1/3–RPS6KA axis (PMID:31538542), and this Drd3-dependent autophagy suppresses NLRP3 inflammasome activation in astrocytes to confer neuroprotection (PMID:35896696). Receptor trafficking and biased signaling are controlled by palmitoylation of the DRD3 C-terminal cytoplasmic domain, which exposes a docking site for the scaffold GIPC1 to redirect internalization (PMID:26787837).

1. 2004 Medium

   Established that DRD3 is required for the pharmacological modulation of morphine reward expression, linking the receptor to drug-conditioned behavior.

   Evidence drd3 knockout mice with morphine conditioned place preference, c-fos imaging, and BP897 pharmacology

   PMID:15371743

   Open questions at the time

   • Does not define the circuit or cellular site of DRD3 action in reward
   • Mechanism of how BP897 reduces somatosensory c-fos is unresolved
2. 2013 Medium

   Showed that a functional human DRD3 coding variant (Ser9Gly) alters reward-related striatal dopamine release, providing in vivo evidence that DRD3 autoreceptor function shapes human reward signaling.

   Evidence PET with [11C]raclopride during a reward task with DRD3 genotype stratification in humans

   PMID:23365649

   Open questions at the time

   • Single modest-sample study without independent replication
   • Does not directly measure receptor affinity or signaling, only inferred from DA displacement
3. 2014 High

   Identified the transcriptional and temporal control of DRD3 by demonstrating NPAS2 directly drives its diurnal rhythm in accumbal neurons, coupling circadian biology to reward.

   Evidence ChIP-seq, AAV-shRNA knockdown in NAc, conditioned place preference, cell-sorting qRT-PCR in mice

   PMID:25444159

   Open questions at the time

   • Does not establish how diurnal Drd3 levels translate to circuit-level reward changes
   • Distinction from CLOCK control not mechanistically explained
4. 2016 Medium

   Defined a post-translational switch for DRD3 signaling, showing that C-terminal palmitoylation recruits GIPC1 to bias receptor trafficking and downstream signaling.

   Evidence Molecular dynamics, Co-IP, live-cell imaging, and site-directed mutagenesis in cultured cells

   PMID:26787837

   Open questions at the time

   • Abstract-level mechanistic detail without reconstitution
   • Identity of the palmitoyl transferase is not defined
   • Physiological consequence in neurons not tested
5. 2017 High

   Demonstrated DRD3 is a necessary and sufficient driver of normal social behavior in lateral septum neurons and the molecular target of early-life-stress-induced social deficits.

   Evidence In vivo Ca2+ imaging, optogenetics, pharmacology, and viral knockdown in mice

   PMID:29276054

   Open questions at the time

   • Downstream effectors of Drd3LS neuron activity in social behavior unresolved
   • Molecular mechanism of ELS-induced Drd3 downregulation not defined
6. 2019 High

   Resolved a DRD3-specific intracellular signaling pathway, showing it activates autophagy via AMPK→RPTOR→MTORC1→ULK1 while uniquely sparing protein synthesis, distinguishing it from DRD2 and direct mTOR inhibitors.

   Evidence Receptor-overexpressing cells, drd3 and drd2 KO mice, pramipexole, autophagy/mTOR Western blots and GFP-LC3 assays

   PMID:31538542

   Open questions at the time

   • Proximal G-protein coupling to AMPK activation not mapped
   • In vivo relevance of preserved protein synthesis not behaviorally tested
7. 2021 High

   Mapped DRD3 plasticity to a defined ventral pallidum circuit, showing distinct VP DRD3+ populations projecting to LHb or VTA control accumbal dopamine potentiation during cocaine relapse.

   Evidence Circuit-specific optogenetics, DRD3 signaling suppression, dopamine release measurements, and cocaine relapse paradigm in mice

   PMID:34048697

   Open questions at the time

   • Molecular nature of DRD3-dependent plasticity in VP not defined
   • Link to the accumbal NPAS2/Drd3 transcriptional axis untested
8. 2022 High

   Connected DRD3 autophagy signaling to innate immune control, showing Drd3-dependent autophagy suppresses astrocytic NLRP3 inflammasome activity and confers neuroprotection.

   Evidence Drd3 siRNA in primary astrocytes, NLRP3 stimulation, autophagy markers, astrocyte-specific Atg5 knockdown in a mouse PD model

   PMID:35896696

   Open questions at the time

   • Whether endogenous dopaminergic tone engages this astrocytic pathway is untested
   • Link between the AMPK-MTORC1 autophagy cascade and NLRP3 suppression not directly traced

• How DRD3's palmitoylation/GIPC1 trafficking switch, its AMPK-autophagy signaling, and its circuit-specific roles in social behavior and reward are integrated into a unified receptor-level mechanism remains open.
• No structural model linking palmitoylation state to specific signaling outputs
• Whether biased signaling controls the autophagy versus circuit-plasticity branches is unknown